Lysyl hydroxylase 2 glucosylates collagen VI to drive lung cancer progression.

Saved in:
Bibliographic Details
Title: Lysyl hydroxylase 2 glucosylates collagen VI to drive lung cancer progression.
Authors: Wang S; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA., Guo H; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, Kentucky, USA., Fukushima R; Department of Biomedical Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Terajima M; Department of Biomedical Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Liu M; Department of Molecular and Cellular Oncology, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Xiao GY; Department of Toxicology and Cancer Biology, The University of Kentucky, Lexington, Kentucky, USA., Koudelková L; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA., Wu C; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA., Liu X; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA., Yu J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA., Burris E; Cell and Molecular Biology, University of St Thomas, Houston, Texas, USA., Xu J; Department of Molecular and Cellular Biology, The Advanced Cell Engineering and 3D Models Core, Baylor College of Medicine, Houston, Texas, USA., Schiavinato A; Center for Biochemistry, University of Cologne, Germany., Russell WK; Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, Texas, USA., Yamauchi M; Department of Biomedical Sciences, Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Tan X; Department of Medicine, Tulane School of Medicine. New Orleans, Louisiana, USA., Kurie JM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas-MD Anderson Cancer Center, Houston, Texas, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2025 Apr 01; Vol. 135 (7). Date of Electronic Publication: 2025 Apr 01.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI189197